Immunitybio (IBRX) Stock Price
$3.21 1.1%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
2 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Immunitybio, AI stock picks, stock alerts and much more.
IBRX AI Stock Analysis
AI stock analysis for IBRX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Immunitybio (IBRX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Immunitybio (IBRX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Immunitybio (IBRX), currently trading at $3.21, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About IBRX
-
ImmunityBio, Inc.
-
Symbol
IBRX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.8B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$24.31 4.3% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.08 1.9% |
3 |
 |
Moderna MRNA |
$27.33 1.5% |
3 |
 |
Anavex Life Sciences AVXL |
$8.21 0.1% |
7 |
 |
BridgeBio Pharma BBIO |
$39.53 1.2% |
7 |
News
IBRX Alternative Data
Web Traffic
Immunitybio receives an estimated 38528 monthly visitors to immunitybio.com, which is down by -22.7% over the last month.
-
Web Traffic
38528
-
Change from Previous Month
22.7%
-
3 Month Change
145.4%
-
YoY Change
145.4%
Facebook Engagement
Immunitybio has engaged 109 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
109
-
Daily Change
12.1%
-
1 Month Change
6.9%
-
3 Month Change
303.7%
-
YoY Change
303.7%
LinkedIn Followers
24,317 are following Immunitybio on LinkedIn, up by 3% over the last month.
-
LinkedIn Followers
24317
-
Daily Change
0.1%
-
1 Month Change
3%
-
3 Month Change
10.1%
Job Postings
Immunitybio has an estimated 16 open job postings, which is down -40.7% over the last month.
-
Job Postings
16
-
Daily Change
0%
-
1 Month Change
40.7%
-
3 Month Change
51.5%
-
YoY Change
51.5%
LinkedIn Employees
According to LinkedIn, Immunitybio has 583 employees, down by -1.9% over the last month.
-
LinkedIn Employees
583
-
Daily Change
0%
-
1 Month Change
1.9%
-
3 Month Change
1.5%
-
YoY Change
1.5%
Reddit Mentions
Immunitybio has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Immunitybio has 9,343 Twitter Followers on its main Twitter (also known as X) account, which is up by 7.4% over the last month.
-
Twitter Followers
9343
-
Daily Change
0.3%
-
1 Month Change
7.4%
-
3 Month Change
171.8%
-
YoY Change
171.8%
Business Outlook
According to employee reviews, the business outlook among employees at Immunitybio is 37 out of 100 (bearish), up by 23.3% over the last month.
-
Business Outlook
37
-
Change from Previous Month
23.3%
-
3 Month Change
8.8%
-
YoY Change
8.8%
News Mentions
Immunitybio was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
IBRX Financials
IBRX Key Metrics
-
Total Revenue
$7.6M
-
Net Income
-$59.2M
-
Earnings per Share
-$0.0807
-
Free cash flow
-$85.1M
-
EBITDA
-$69.4M
-
EBITDA Ratio
-9.18962
-
Total Assets
$382.9M
IBRX 2-year Revenue & Income
IBRX 2-year Free Cash Flow
IBRX Technicals
IBRX SMA
IBRX RSI
FAQ
What's the current price of Immunitybio (IBRX) Stock?
The price of an Immunitybio (IBRX) share is $3.21.
What's the market cap of Immunitybio?
The current market cap of Immunitybio is 2.8B.
Should I buy or sell IBRX?
Immunitybio shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Immunitybio is better viewed as a hold or accumulate position while waiting for further developments.
Is Immunitybio a good investment?
The current analysis of Immunitybio's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Immunitybio's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Immunitybio (IBRX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Immunitybio stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Immunitybio (IBRX) that investors often compare it to?
Immunitybio (IBRX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Immunitybio's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Immunitybio's stock price to be around $3.37 in 2026. Starting from the current price of $3.21, this represents a 5.2% change in price, indicating a bullish outlook for the stock.
How to buy Immunitybio (IBRX) Stock?
Immunitybio stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Immunitybio shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.